Well, we all want these drugs on the market as fast as possible but I would be concerned about any proposal to remove FDA's ability to require clinical data when FDA thinks it is essential to assure that these drugs are safe and effective, so I certainly agree with the position NORD has been taking.
Waxman expresses concern over proposals that could weaken FDA's data requirements for drug approvals.
Share
More from Henry Waxman
The House's need for all the facts surrounding suspected Presidential offences cannot of course be circumscribed by an executive determination of what is relevant.
I want to take this opportunity to pay tribute to Ralph Hall, particularly for his earlier years in the House of Representatives when he was a Democrat. He came on the Energy and Commerce Committee early. We sometimes think about Democrats…
Today's hearing is on a topic about which many Americans have strong feelings...
Mr. Whitfield mentioned that the National Association of Clean Air Agencies would like timely implementation guidance. That is true. But just yesterday, they wrote a letter making clear they oppose this bill. I insert in the Record the…
Other voices in this conversation
